account_balanceBalance Sheet (BS) Summary

Updated: 06/30/20262026 Q2

Total Assets

896.1M USD

YoY +35.5%

Shareholders' Equity

654.1M USD

YoY +32.1%

Equity Ratio

73%

YoY -1.9pt

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %

806040200

2021

2022

2023

2024

2025

Balance Sheet Details

Unit: USD

Item

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Cash

Cash and Equivalents

Short-term Investments

Net Receivables

Inventory

Other Current Assets

Total Current Assets

165.60M

248.48M

15.59M

54.90M

42.61M

527.18M

Goodwill

Intangible Assets

Property, Plant and Equipment

Property, Plant and Equipment Net

Long-term Investments

Other Assets

Other Non-current Assets

Net Tangible Assets

Non-current Assets Total

Total Assets

0

15.25M

11.75M

0

11.31M

748.38M

236.46M

763.63M

Accounts Payable

Short-term Debt

Short/Current Long-term Debt

Current Deferred Revenue

Other Current Liabilities

Total Current Liabilities

2.03M

2.99M

31.81M

102.36M

139.18M

Long-term Debt

Long-term Debt Total

Capital Lease Obligations

Other Non-current Liabilities

Net Debt

Non-current Liabilities Total

Total Liabilities

0

9.50M

6.51M

18.52M

-156.10M

56.84M

196.03M

Common Stock

Common Stock Shares Outstanding

Additional Paid-in Capital

Retained Earnings

Accumulated Other Comprehensive Income

Other Stockholder Equity

Treasury Stock

Total Stockholder Equity

21,000

78.98M

1.03B

-462.14M

-25,000

0

567.61M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan

Kiniksa Pharmaceuticals International, plc

account_balanceBalance Sheet (BS) Summary

Asset & Liability Mix

Equity Ratio Trend (5 Years)

Balance Sheet Details

Unlock Long-Term Balance Sheet Data